Modeling of the agonist binding site of serotonin human 5-HT1A, 5-HT1Dα and 5-HT1Dβ receptors
- 31 December 1997
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 32 (1) , 59-69
- https://doi.org/10.1016/s0223-5234(97)84362-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Construction of a Detailed Serotoninergic 5‐HT2a Receptor ModelArchiv der Pharmazie, 1995
- Synthesis and Biological Activity of 3-[2-(Dimethylamino)ethyl]-5-[(1,1-dioxo-5-methyl-1,2,5-thiadiazolidin-2-yl)methyl]-1H-indole and Analogs: Agonists for the 5-HT1D ReceptorJournal of Medicinal Chemistry, 1994
- Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptorsJournal of Medicinal Chemistry, 1993
- The development of a highly selective 5‐HT1 receptor agonist, sumatriptan, for the treatment of migraineDrug Development Research, 1992
- Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopyJournal of Molecular Biology, 1990
- The structure of bacteriorhodopsin and its relevance to the visual opsins and other seven-helix G-protein coupled receptorsPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1990
- Comparative Neuropharmacology of Dihydroergotamine and Sumatriptan (GR 43175)Headache: The Journal of Head and Face Pain, 1989
- Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sitesEuropean Journal of Pharmacology, 1989
- POSSIBLE BENEFIT OF GR43175, A NOVEL 5-HT1-LIKE RECEPTOR AGONIST, FOR THE ACUTE TREATMENT OF SEVERE MIGRAINEThe Lancet, 1988
- The opsin family of proteinsBiochemical Journal, 1986